These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22353750)

  • 21. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional management of dialysis patients: balancing among nutrient intake, dialysis dose, and nutritional status.
    Nakao T; Matsumoto H; Okada T; Kanazawa Y; Yoshino M; Nagaoka Y; Takeguchi F
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S133-6. PubMed ID: 12612970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy.
    Keshaviah P; Collins AJ; Ma JZ; Churchill DN; Thorpe KE
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S48-52. PubMed ID: 11792762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
    Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
    Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between brain natriuretic peptide, troponin I and QT dispersion in asymptomatic dialysis patients.
    Taskapan MC; Taskapan H; Ulutas O; Orhan M; Sahin I
    Ren Fail; 2007; 29(2):221-5. PubMed ID: 17365940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG
    Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
    Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
    Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?
    Sezer S; Ozdemir N; Arat Z; Güz G; Sengül S; Akman B; Haberal A; Turan M; Haberal M
    Adv Perit Dial; 2000; 16():177-81. PubMed ID: 11045288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN; Morgan AG; Burden RP
    West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of renal replacement therapies on serum gastrointestinal system hormones.
    Borazan A; Cavdar Z; Saglam F
    Ren Fail; 2007; 29(8):1019-23. PubMed ID: 18067050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal dialysis versus hemodialysis: a five-year comparison of survival and effects on the cardiovascular system, erythropoiesis, and calcium metabolism.
    Suzuki T; Kanno Y; Nakamoto H; Okada H; Sugahara S; Suzuki H
    Adv Perit Dial; 2003; 19():148-54. PubMed ID: 14763052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal rhythm of blood pressure, heart rate and adrenergic activity in patients with normotension treated with continuous ambulatory peritoneal dialysis and haemodialysis.
    Baranowicz-Gaszczyk I; Jóźwiak L; Bednarek-Skublewska A; Ksiazek A
    Rocz Akad Med Bialymst; 2005; 50():252-6. PubMed ID: 16358978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxalate removal by differing dialysis techniques.
    Dell'Aquila R; Feriani M; Mascalzoni E; Bragantini L; Ronco C; La Greca G
    ASAIO J; 1992; 38(4):797-800. PubMed ID: 1450473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD.
    Martínez ME; Miguel JL; Gómez P; Selgas R; Salinas M; Gentil M; Mateos F; Montero JL; Sánchez Sicilia L
    Clin Nephrol; 1983 May; 19(5):250-3. PubMed ID: 6851265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life in patients on peritoneal dialysis in Serbia: comparison with hemodialysis.
    Lausevic M; Nesic V; Stojanovic M; Stefanovic V
    Artif Organs; 2007 Dec; 31(12):901-10. PubMed ID: 17924989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic nightly tidal peritoneal dialysis.
    Twardowski ZJ; Prowant BF; Nolph KD; Khanna R; Schmidt LM; Satalowich RJ
    ASAIO Trans; 1990; 36(3):M584-8. PubMed ID: 2252757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.